ReviewCancer genetics and cytogenetics2008
Aggressive angiomyxoma with t(12;21) and HMGA2 rearrangement: report of a case and review of the literature.
Review in Cancer genetics and cytogenetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 60 citations in OpenAlex.
- A Low-Grade Angiomyxofibromatous Tumor of the Falx Cerebelli: A Mimic of Fourth Ventricular Tumors.Asian journal of neurosurgery · 2025Article
- Xanthogranulomatous epithelial tumors/keratin-positive giant cell-rich tumors involving the head and neck: report of seven cases and review of the literature.Virchows Archiv : an international journal of pathology · 2024Review
- Radio-pathological and Clinical Correlation of Aggressive Angiomyxoma: Experience of a Tertiary Care Cancer Hospital.The Indian journal of radiology & imaging · 2021Article
- Aggressive angiomyxoma of the ischioanal fossa in a post-menopausal woman.Annals of the Royal College of Surgeons of England · 2021Review
- Radiomic features from MRI distinguish myxomas from myxofibrosarcomas.BMC medical imaging · 2019Article
- The extracellular domain of epithelial cell adhesion molecule (EpCAM) enhances multipotency of mesenchymal stem cells through EGFR-LIN28-LET7 signaling.The Journal of biological chemistry · 2019Article
- Surgical Resection of Retroperitoneal Aggressive Angiomyxoma: Case Report and Review of the Literature.Cureus · 2017Review
- 50-year-old man with a falcine mass.Brain pathology (Zurich, Switzerland) · 2017Article
- Clinicopathological Features and Treatment Analysis of Rare Aggressive Angiomyxoma of the Female Pelvis and Perineum - a Retrospective Study.Pathology oncology research : POR · 2017Article
- Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2016Article
- Deep angiomyxoma of retroperitoneum presenting as a perineal lump in a young woman.BMJ case reports · 2013Article
- Embryonic stem cell markers.Molecules (Basel, Switzerland) · 2012Review
- Mutation of an X chromosome in aggressive angiomyxoma: Report of a case and review of the literature.Gynecologic oncology case reports · 2011Article
- Fusion of High Mobility Group AT-hook 2 Gene (Cancer genomics & proteomicsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
Conventional cytogenetic analysis of an aggressive angiomyxoma of the rectal wall of a 72-year-old woman revealed a translocation between the long arms of chromosomes 12 and 21, with the karyotype 46,XX,t(12;21)(q15;q21.1). Involvement of the HMGA2 gene locus (12q15) was confirmed by fluorescence in situ hybridization using an HMGA2 breakpoint flanking probe set performed on metaphase and interphase cells from an in situ culture of fresh lesional tissue. Karyotypic rearrangements of 12q13 approximately q15 are considered recurrent in aggressive angiomyxoma, although reported in only five previous cases. Translocation partner chromosome 21 is unique to the present case.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.